Cargando…

Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer

BACKGROUND: The efficacy of bevacizumab in non-small cell lung cancer (NSCLC) patients is unsatisfactory, and the selection of suitable patients is still challenging. Given the epigenetic modifications can contribute to an aberrant regulation of angiogenesis and microenvironment, we investigated DNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Butuo, Jiang, Chao, Xu, Yiyue, Fan, Xinyu, Yang, Linlin, Zou, Bing, Fan, Bingjie, Wang, Linlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338664/ https://www.ncbi.nlm.nih.gov/pubmed/35906610 http://dx.doi.org/10.1186/s12885-022-09918-1

Ejemplares similares

Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab
por: Li, Butuo, et al.
Publicado: (2023)

NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma
por: Xu, Yiyue, et al.
Publicado: (2022)

A novel deep learning prognostic system improves survival predictions for stage III non‐small cell lung cancer
por: Yang, Linlin, et al.
Publicado: (2022)

The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients
por: Li, Butuo, et al.
Publicado: (2019)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2021)

Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients
por: Guo, Meiying, et al.
Publicado: (2020)

Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer
por: Fan, Xinyu, et al.
Publicado: (2023)

Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer
por: Qin, Wenru, et al.
Publicado: (2022)

Does ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature review
por: Liu, Zhichao, et al.
Publicado: (2018)

Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review
por: Li, Butuo, et al.
Publicado: (2021)

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
por: Mu, Fengchun, et al.
Publicado: (2023)

Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases
por: Shang, Shuheng, et al.
Publicado: (2018)

Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durable Response to Anlotinib: A Case Report
por: Qin, Wenru, et al.
Publicado: (2022)

Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer
por: Li, Butuo, et al.
Publicado: (2020)

Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC
por: Li, Butuo, et al.
Publicado: (2018)

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer
por: Xu, Yiyue, et al.
Publicado: (2021)

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2018)

Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis
por: Guo, Meiying, et al.
Publicado: (2019)

Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer
por: Hsu, Ping-Ching, et al.
Publicado: (2020)

Genome-wide DNA methylation profiling of non-small cell lung carcinomas
por: Carvalho, Rejane Hughes, et al.
Publicado: (2012)

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer
por: Shi, Yuan-Xiang, et al.
Publicado: (2017)

Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report
por: Yan, Wenxing, et al.
Publicado: (2020)

Bevacizumab treatment for advanced non-small cell lung cancer: A case report
por: FAN, YUN, et al.
Publicado: (2013)

The Impact of Recent Alcohol Use on Genome Wide DNA Methylation Signatures
por: Philibert, Robert A., et al.
Publicado: (2012)

Epigenome‐wide analyses identify DNA methylation signatures of dementia risk
por: Walker, Rosie M., et al.
Publicado: (2020)

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)

Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell
por: Xu, Jiawei, et al.
Publicado: (2016)

Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases
por: Li, Butuo, et al.
Publicado: (2020)

Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms
por: Freeman, Joshua R, et al.
Publicado: (2016)

Epigenome-Wide Tobacco-Related Methylation Signature Identification and Their Multilevel Regulatory Network Inference for Lung Adenocarcinoma
por: Dong, Yan-Mei, et al.
Publicado: (2020)

MRCNN: a deep learning model for regression of genome-wide DNA methylation
por: Tian, Qi, et al.
Publicado: (2019)

Genome-wide methylation profiling reveals differentially methylated genes in blood DNA of small-cell lung cancer patients
por: He, Yanqi, et al.
Publicado: (2022)

Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer
por: Kim, Jeong Yeon, et al.
Publicado: (2020)

Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia
por: Nordlund, Jessica, et al.
Publicado: (2013)

NSD1 mutations generate a genome-wide DNA methylation signature
por: Choufani, S., et al.
Publicado: (2015)

Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review
por: Bao, Youting, et al.
Publicado: (2018)

Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
por: Chen, Youdinghuan, et al.
Publicado: (2018)

Construction of subtype-specific prognostic gene signatures for early-stage non-small cell lung cancer using meta feature selection methods
por: Liu, Chunshui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s22lmdr8d35i5gkm9p4todo53n